Depression

Showing NaN - NaN of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bipolar I Disorder, Mania, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar I Disorder
  • +2 more
  • Little Rock, Arkansas
  • +111 more
Dec 12, 2022

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

Depression, Anxiety, Primary Health Care Trial in Little Rock (IntelliCare)

Completed
  • Depression
  • +2 more
  • IntelliCare
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Apr 26, 2019

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar Disorder
  • Depression
  • Birmingham, Alabama
  • +88 more
Feb 19, 2019

Bipolar Disorder, Depression Trial in Worldwide (Cariprazine, Placebo)

Completed
  • Bipolar Disorder
  • Depression
  • Little Rock, Arkansas
  • +73 more
Jan 10, 2019

Depressive Disorder, Depression, Depressive Disorder, Major Trial in Worldwide (OPC-34712, Escitalopram, Fluoxetine)

Completed
  • Depressive Disorder
  • +4 more
  • Birmingham, Alabama
  • +143 more
Sep 14, 2018

Hepatitis C, Depression Trial in United States (Depression collaborative care model)

Completed
  • Hepatitis C
  • Depression
  • Depression collaborative care model
  • Little Rock, Arkansas
  • +3 more
Apr 12, 2016

Disease Response to ECT in Depression

Completed
  • Depression
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Feb 2, 2016

    Depression Trial in Worldwide (Duloxetine, Escitalopram, BMS-820836 Placebo)

    Completed
    • Depression
    • Birmingham, Alabama
    • +92 more
    Sep 23, 2015

    Depression Trial in Worldwide (Placebo matching with BMS-820836, BMS-820836)

    Terminated
    • Depression
    • Birmingham, Alabama
    • +143 more
    Sep 23, 2015

    Depression Trial in Worldwide (Duloxetine, Placebo matching with BMS-820836, BMS-820836)

    Completed
    • Depression
    • Little Rock, Arkansas
    • +83 more
    Sep 23, 2015

    MDD, Depression Trial in India, United States (TC-5214, Placebo)

    Completed
    • Major Depressive Disorder
    • Depression
    • Tuscaloosa, Alabama
    • +50 more
    Mar 14, 2014

    MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)

    Completed
    • Major Depressive Disorder
    • +2 more
    • Birmingham, Alabama
    • +93 more
    Mar 14, 2014

    MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

    Completed
    • Major Depressive Disorder
    • Depression
    • Birmingham, Alabama
    • +98 more
    Mar 14, 2014

    Depression, Depressive Disorder, Depressive Disorder, Major Trial in United States (Desvenlafaxine administered as a succinate

    Completed
    • Depression
    • +2 more
    • Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR)
    • Placebo
    • Birmingham, Alabama
    • +36 more
    Apr 9, 2012

    Depression Trial in Little Rock (Telemedicine-Based Collaborative Care, Practice Based Collaborative Care)

    Completed
    • Depression
    • Telemedicine-Based Collaborative Care
    • Practice Based Collaborative Care
    • Little Rock, Arkansas
      University of Arkansas for Medical Science
    Aug 31, 2011

    Depression, MDD Trial in United States (Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR))

    Completed
    • Depression
    • Major Depressive Disorder
    • Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)
    • Little Rock, Arkansas
    • +8 more
    Feb 18, 2011

    Depression Trial in United States (blood draw)

    Completed
    • Depression
    • blood draw
    • Birmingham, Alabama
    • +52 more
    Jan 5, 2011